Story perspectives
New Study Targets Toxoplasmosis Parasite for Treatment
10/27/2025
24 2
1 of 1
Story summary
- A study led by Rajshekhar Gaji at the Virginia-Maryland College of Veterinary Medicine identifies TgAP2X-7 as a potential target for treating Toxoplasma gondii.
- Toxoplasma gondii affects about 40 million Americans.
- Degrading TgAP2X-7 in the parasite reduced its invasion of human cells.
- The findings could lead to new therapeutic options for toxoplasmosis, particularly for patients with weakened immune systems.
